Clearside Biomedical, Inc. Announces 50th Patient Enrolled Using Suprachoroidal Drug Administration

ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, which develops first-in-class drug therapies to treat diseases of the eye, announces enrollment of 50th patient using suprachoroidal (SCS™) drug administration.